Lyfstone

medical devices

About

Lyfstone is a med-tech company focused on developing innovative biomarker diagnostics for the orthopaedic market. Founded in 2016 and headquartered in Abcoude, The Netherlands, the company specializes in enhancing the detection of joint-related conditions, particularly periprosthetic joint infections (PJI) and implant loosening. Their flagship product, Lyfstone® Calprotectin for Synovial Fluid, measures calprotectin levels in joint fluid to aid in diagnosing infections and inflammation around joint implants. This product was developed in collaboration with Calpro AS, a Norwegian company with extensive expertise in calprotectin analysis. Lyfstone’s diagnostics are CE-IVD compliant, ensuring they meet European regulatory standards for in vitro diagnostic medical devices. The company also maintains a network of professional distributors throughout Europe to support access to their products for healthcare professionals, including surgeons and clinical laboratories.

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting

Keywords

othopaedics joint implants diagnostics lfd biomarker diagnostics early diagnosis immunoassay medical devices medical equipment and supplies manufacturing pji diagnosis rapid diagnostic test inflammation marker calprotectin lateral flow test synovial calprotectin elisa calprotectin in joint infections periprosthetic joint infection orthopaedic infection biomarker pji diagnostic tool synovial calprotectin pji intraoperative testing clinical studies orthopaedics b2b bedside test point-of-care calprotectin assay pji biomarker validation synovial fluid biomarker biotechnology biomarker detection joint infection detection

Location

49 Papehof, Abcoude, Utrecht, Netherlands, 1391 BE

Related Companies

Companies in the same industry